395 related articles for article (PubMed ID: 26621170)
1. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
Azanza JR; Sádada B; Reis J
Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
[TBL] [Abstract][Full Text] [Related]
2. The lipid formulations of amphotericin B.
Herbrecht R; Natarajan-Amé S; Nivoix Y; Letscher-Bru V
Expert Opin Pharmacother; 2003 Aug; 4(8):1277-87. PubMed ID: 12877636
[TBL] [Abstract][Full Text] [Related]
3. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
4. [Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story].
Azanza Perea JR; Barberán J
Rev Esp Quimioter; 2012 Mar; 25(1):17-24. PubMed ID: 22488537
[TBL] [Abstract][Full Text] [Related]
5. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
7. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.
Bellmann R; Egger P; Wiedermann CJ
Clin Infect Dis; 2003 Jun; 36(11):1500-1. PubMed ID: 12766850
[No Abstract] [Full Text] [Related]
8. A comparative review of conventional and lipid formulations of amphotericin B.
Robinson RF; Nahata MC
J Clin Pharm Ther; 1999 Aug; 24(4):249-57. PubMed ID: 10475983
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based formulations of amphotericin B.
Veerareddy PR; Vobalaboina V
Drugs Today (Barc); 2004 Feb; 40(2):133-45. PubMed ID: 15045035
[TBL] [Abstract][Full Text] [Related]
10. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
11. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
Pahissa A
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
[No Abstract] [Full Text] [Related]
12. Comparison between liposomal formulations of amphotericin B.
Adler-Moore JP; Gangneux JP; Pappas PG
Med Mycol; 2016 Mar; 54(3):223-31. PubMed ID: 26768369
[TBL] [Abstract][Full Text] [Related]
13. Lipid formulations of amphotericin B.
Jones E; Goldman M
Cleve Clin J Med; 1998 Sep; 65(8):423-7. PubMed ID: 9769563
[TBL] [Abstract][Full Text] [Related]
14. Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer.
Groll AH; Müller FM; Piscitelli SC; Walsh TJ
Klin Padiatr; 1998; 210(4):264-73. PubMed ID: 9743964
[TBL] [Abstract][Full Text] [Related]
15. New methods for delivery of antifungal agents.
Meunier F
Rev Infect Dis; 1989; 11 Suppl 7():S1605-12. PubMed ID: 2690298
[TBL] [Abstract][Full Text] [Related]
16. Pseudohyperphosphatemia associated with high-dose liposomal and lipid complex amphotericin B when tested with Synchron LX 20 (Beckman/Coulter) phosphorous assay.
Shiu JR; Forgie SE; Pinsk M; Romanick M
J Pediatr Hematol Oncol; 2012 May; 34(4):e155-7. PubMed ID: 22146534
[TBL] [Abstract][Full Text] [Related]
17. Liposomal and lipid-based formulations of amphotericin B.
de Marie S
Leukemia; 1996 Jun; 10 Suppl 2():s93-6. PubMed ID: 8649062
[TBL] [Abstract][Full Text] [Related]
18. Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B.
Bellmann R; Cleary JD; Sterba J
Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-8. PubMed ID: 19537331
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.
Steimbach LM; Tonin FS; Virtuoso S; Borba HH; Sanches AC; Wiens A; Fernandez-Llimós F; Pontarolo R
Mycoses; 2017 Mar; 60(3):146-154. PubMed ID: 27878878
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B: clinical experience and perspectives.
Gibbs WJ; Drew RH; Perfect JR
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):167-81. PubMed ID: 15918775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]